Authors :
Dr. Rohit Sane; Dr. Gurudatta Amin; Dr. Pravin Ghadigaonkar; Dr. Priyadarshini Bhalekar; Dr. Trupti Pathare; Dr. Priyanka Pathare
Volume/Issue :
Volume 11 - 2026, Issue 5 - May
Google Scholar :
https://tinyurl.com/yc8x78rm
Scribd :
https://tinyurl.com/5er39n3x
DOI :
https://doi.org/10.38124/ijisrt/26May1648
Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.
Abstract :
Background:
Type 2 Diabetes Mellitus (T2DM) is a growing metabolic disorder with rising prevalence globally. Conventional
pharmacological management, while effective, is often associated with long-term side effects and medication dependence.
Ayurveda offers a holistic approach to Prameha (diabetes) through multi-modal interventions addressing metabolic
dysfunction at its root. This study evaluates the clinical outcomes of an integrated Ayurvedic protocol combining
individualized Panchakarma therapies, oral herbal medications, and a structured low-calorie diet in patients with T2DM.
Methods:
This retrospective observational study analyzed data from 29 patients (21 males, 8 females; mean age 45.4 ± 11.3
years) diagnosed with T2DM, treated at the Kharadi branch of a specialised Ayurvedic diabetes management clinic.
Patients received one of two Panchakarma-based care plans — CDC-SP therapy (BMI ≥ 23) or CDC-KP therapy (BMI <
23) — comprising Snehan, Swedan, and Basti with a herbal preparation of Gudmar, Daru Haridra, and Yashti Madhu.
All patients were concurrently prescribed oral herbal medications and an 800 kcal low-calorie, low-carbohydrate, highprotein, high-fat Prameha Diet Box. Primary outcomes included HbA1c and random blood sugar (RBS); secondary
outcomes included body weight, BMI, abdominal girth, and blood pressure. Paired t-tests were used for pre/post
comparisons.
Keywords :
Type 2 Diabetes Mellitus · Panchakarma · Ayurveda · Prameha · Basti · HbA1c · Gudmar · Calorie-Restricted Diet · Integrative Medicine · Glycaemic Control · Madhavbaug · Koregaon Park.
References :
- International Diabetes Federation. IDF Diabetes Atlas, 11th edn. Brussels, Belgium: International Diabetes Federation, 2024. Available from: https://www.diabetesatlas.org
- GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203–234. doi:10.1016/S0140-6736(23)01301-6
- Anjana RM, Pradeepa R, Unnikrishnan R, et al. Geographical variation in the prevalence and risk factors of diabetes and prediabetes in India: results from the ICMR-INDIAB national study. Diabetologia. 2023;66(12):2252–2263.
- Charaka Samhita. Sutrasthana, Nidanasthana, Chikitsasthana. Varanasi: Chaukhamba Surbharati Prakashan; 2011.
- Sushruta Samhita. Chikitsasthana. Varanasi: Chaukhamba Sanskrit Pratishthan; 2010.
- Revandkar V, Lathi A, Jain A, et al. Role of Aahar and Panchakarma on restoration of euglycemia in patients of type 2 diabetes mellitus — a retrospective observational study. Int J Res Med Sci. 2023;11(11):4077–4081. doi:10.18203/2320-6012.ijrms20233297
- Kshirsagar J, Wankhade V, Nandedkar S, et al. Impact of Ayurvedic Panchakarma along with lifestyle modification in restoring glucose tolerance in type 2 diabetes mellitus. Int J Basic Clin Pharmacol. 2024;13(5):669–672.
- Hegde SV, Adhikari P, Bhuta S, Nagalakshmi MK, D'Souza V. Effect of a holistic program of yoga and Ayurvedic Panchakarma in type 2 diabetes mellitus: a pilot study. J Complement Integr Med. 2013;8. doi:10.2202/1553-3840.1365
- Chattopadhyay K, Chandrasekaran AM, Praveen PA, et al. Effectiveness and safety of Ayurvedic medicines in type 2 diabetes mellitus management: a systematic review and meta-analysis. Front Med. 2022;9:821810. doi:10.3389/fmed.2022.821810
- Laha S, Paul S. Anti-diabetic potential of Gymnema sylvestre: a review. Pharmacognosy J. 2019;11(6s):1111–1117.
- Porchezhian E, Dobriyal RM. An overview on the advances of Gymnema sylvestre: chemistry, pharmacology and patents. Pharmazie. 2003;58(1):5–12.
- Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712–717. doi:10.1016/j.metabol.2008.01.013
- Fliegerová K, Mahayri TM, Sechovcová H, et al. Diabetes and gut microbiome. Front Microbiol. 2025;15:1487024. doi:10.3389/fmicb.2024.1487024
- Goldenberg JZ, Day A, Brinkworth GD, et al. Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis. BMJ. 2021;372:m4743. doi:10.1136/bmj.m4743
- Churuangsuk C, Hall J, Reynolds A, et al. Diets for weight management in adults with type 2 diabetes: an umbrella review. Diabetologia. 2022;65(1):14–36. doi:10.1007/s00125-021-05577-2
- Lean MEJ, Leslie WS, Barnes AC, et al. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes Endocrinol. 2019;7(5):344–355.
- Taheri S, Zaghloul H, Chagoury O, et al. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I). Lancet Diabetes Endocrinol. 2020;8(6):477–489.
- McInnes N, Smith A, Otto R, et al. Remission of type 2 diabetes with very low-calorie diets — a narrative review. Nutrients. 2021;13(6):1890. doi:10.3390/nu13061890
- Li Y, Liu B, Zhao H, et al. Effects of low-carbohydrate diet on glucose and lipid metabolism in overweight or obese patients with type 2 diabetes: a meta-analysis of randomized controlled trials. Front Nutr. 2024;11:1516086.
- Gonzalez A, Krieg R, Massey HD, et al. Sodium butyrate ameliorates insulin resistance and renal failure in CKD rats by modulating intestinal permeability and mucin expression. Nephrology Dialysis Transplantation. 2019;34(5):783–794.
- Mohan V, Unnikrishnan R, Shanthi Rani CS. Are calorie-restricted diets safe in Indians? Indian J Med Res. 2021;153(3):321–323.
- Takeuchi T, Kubota T, Nakanishi Y, et al. Gut microbial carbohydrate metabolism contributes to insulin resistance. Nature. 2023;621(7978):389–395. doi:10.1038/s41586-023-06466-x
Background:
Type 2 Diabetes Mellitus (T2DM) is a growing metabolic disorder with rising prevalence globally. Conventional
pharmacological management, while effective, is often associated with long-term side effects and medication dependence.
Ayurveda offers a holistic approach to Prameha (diabetes) through multi-modal interventions addressing metabolic
dysfunction at its root. This study evaluates the clinical outcomes of an integrated Ayurvedic protocol combining
individualized Panchakarma therapies, oral herbal medications, and a structured low-calorie diet in patients with T2DM.
Methods:
This retrospective observational study analyzed data from 29 patients (21 males, 8 females; mean age 45.4 ± 11.3
years) diagnosed with T2DM, treated at the Kharadi branch of a specialised Ayurvedic diabetes management clinic.
Patients received one of two Panchakarma-based care plans — CDC-SP therapy (BMI ≥ 23) or CDC-KP therapy (BMI <
23) — comprising Snehan, Swedan, and Basti with a herbal preparation of Gudmar, Daru Haridra, and Yashti Madhu.
All patients were concurrently prescribed oral herbal medications and an 800 kcal low-calorie, low-carbohydrate, highprotein, high-fat Prameha Diet Box. Primary outcomes included HbA1c and random blood sugar (RBS); secondary
outcomes included body weight, BMI, abdominal girth, and blood pressure. Paired t-tests were used for pre/post
comparisons.
Keywords :
Type 2 Diabetes Mellitus · Panchakarma · Ayurveda · Prameha · Basti · HbA1c · Gudmar · Calorie-Restricted Diet · Integrative Medicine · Glycaemic Control · Madhavbaug · Koregaon Park.